Repros Therapeutics Inc.
RPRX
NGS
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
42.45
USD
-0.06
(-0.14%)
Optionable: Yes Market Cap: 18,488 M 90-day average vol: 0
Previous close: 42.51 Open: 42.5 Bid: 43.5 Ask: 43.5
52 week range
0.00 0.00
Last updated: Monday 8th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 10.73 |
Price per Book TTM ($) | 3.22 |
PE Ratio (TTM) | 29.70 |
Book Value per Share ($) | 13.27 |
5 Year PE Range26.7 |
Returns
7 Day Return | -0.75% | |
1 Month Return | -1.19% | |
3 Month Return | 13.64% | |
1 Year Return | 17.49% | |
3 Year Return | -9.73% | |
5 Year Return | -9.73% | |
YTD Return | 6.52% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 47.85 |
14 Day SMA ($) | 43.03 |
14 Day EMA ($) | 42.87 |
Money Flow Index | 69.96 |
Average True Range | 0.93 |
50 Day SMA ($) | 41.83 |
200 Day SMA ($) | 40.33 |
ADX | 18.41 |
MACD | 0.19 |
Growth
Free Cash Flow QoQ Growth | -6.06% |
Free Cash Flow YoY Growth | -0.84% |
Revenue YoY Growth | 7.87% |
EPS QoQ Growth | 0.00% |
Revenue QoQ Growth | -2.37% |
EPS YoY Growth | 12.88% |
Chart
News
Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
Yahoo Finance 3/3/2022
Royalty Pharma Offers A Unique Long-Term Investment Opportunity
Seeking Alpha 3/1/2022
Royalty Pharma Announces Inaugural Investor Day
Yahoo Finance 2/16/2022
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 2/15/2022
Royalty Pharma reports Q4 results
Seeking Alpha 2/15/2022
Royalty Pharma Reports Q4 and Full Year 2021 Results
Yahoo Finance 2/15/2022
Royalty Pharma Q4 2021 Earnings Preview
Seeking Alpha 2/14/2022
S&co Inc Buys Royalty Pharma PLC, Edwards Lifesciences Corp, Procter & Gamble Co, Sells ...
Yahoo Finance 2/8/2022
Financial Consulate, Inc Buys iShares J.P. ...
Yahoo Finance 2/7/2022
Rivian, Robinhood, Bumble: Many top IPOs of 2021 are struggling
Yahoo Finance 2/7/2022
Torray LLC Buys General Motors Co, T. Rowe Price Group Inc, Applied Materials Inc, Sells Intel ...
Yahoo Finance 2/4/2022
Largest IPOs of 2021 struggling as public companies
Yahoo Finance 2/4/2022
State of New Jersey Common Pension Fund D Buys Canadian Pacific Railway, Airbnb Inc, Lucid ...
Yahoo Finance 1/31/2022
Oxler Private Wealth LLC Buys Ford Motor Co, Verizon Communications Inc, Zoom Video ...
Yahoo Finance 1/27/2022
Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022
Yahoo Finance 1/20/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 60.7
Financials
RPRX Income Statement
Annual
| Invalid date | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|
| Total revenues | 1,598 M | 1,795 M | 1,814 M | 2,122 M | 2,289 M | |
| Cost of sales | -33 M | -33 M | -24 M | -23 M | -23 M | |
| Gross operating profit | 1,598 M | 1,795 M | 1,814 M | 2,122 M | 2,289 M | |
| Selling Gen & administrative expense | 507 M | 5 M | -916 M | 478 M | 636 M | |
| Research & development expense | 118 M | 393 M | 83 M | 26 M | 200 M | |
| Operating income | 940 M | 1,364 M | 2,623 M | 1,595 M | 1,431 M | |
| floaterest income | 0 | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | |
| Other income net | 644 M | 409 M | 84 M | 235 M | -77 M | |
| Pre-tax Income (EBT) | 1,343 M | 1,518 M | 2,461 M | 1,702 M | 1,241 M | |
| Income taxes | 0 | 0 | 0 | 0 | 0 | |
| Net income from total operations | 1,343 M | 1,518 M | 2,461 M | 1,702 M | 1,241 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | |
| Total net income | 1,210 M | 1,378 M | 2,349 M | 975 M | 620 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | |
| Net income available for common | 1,343 M | 1,518 M | 2,461 M | 1,702 M | 1,241 M | |
| Depreciation | 33 M | 33 M | 24 M | 23 M | 23 M | |
| Amortization | 33 M | 33 M | 24 M | 23 M | 23 M | |
| Operating income before depreciation (EBITDA) | 1,624 M | 1,831 M | 2,754 M | 1,882 M | 1,430 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | |
| Basic EPS total | 3.42 | 3.89 | 3.35 | 1.32 | 1.49 | |
| Diluted EPS total | 3.42 | 3.89 | 3.35 | 1.32 | 1.49 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!